Ftse Mib
34.013,33
1,14%
DAX
18.166,00
0,96%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.597,37
0,93%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Crinetics Pharmaceuticals Inc (CRNX) Crinetics Pharmaceuticals Inc (CRNX) Notizie

Crinetics Pharmaceuticals Inc

CRNX
47,20
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:05:09
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202421:15EDGAR2Form D - Notice of Exempt Offering of Securities
07/3/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/2/202422:09EDGAR2Form 8-K - Current report
14/2/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202419:03EDGAR2Form 144 - Report of proposed sale of securities
12/1/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202418:10EDGAR2Form 144 - Report of proposed sale of securities
08/1/202414:03EDGAR2Form 8-K - Current report
04/1/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:11EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:44EDGAR2Form 144 - Report of proposed sale of securities
27/12/202323:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202317:47EDGAR2Form 144 - Report of proposed sale of securities
23/12/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202323:28EDGAR2Form 144 - Report of proposed sale of securities
18/12/202322:12EDGAR2Form 8-K - Current report
13/12/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:35EDGAR2Form 8-K - Current report
11/12/202319:48EDGAR2Form 144 - Report of proposed sale of securities
29/11/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202317:40EDGAR2Form 144 - Report of proposed sale of securities
13/11/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/11/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:04EDGAR2Form 8-K - Current report
07/11/202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202300:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:00EDGAR2Form 144 - Report of proposed sale of securities
02/11/202321:02EDGAR2Form 144 - Report of proposed sale of securities
01/11/202321:44EDGAR2Form 144 - Report of proposed sale of securities
13/9/202323:23EDGAR2Form 8-K - Current report
13/9/202323:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/9/202322:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/9/202312:05EDGAR2Form 8-K - Current report
16/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:01EDGAR2Form 8-K - Current report
13/7/202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202322:14EDGAR2Form 144 - Report of proposed sale of securities
12/7/202322:25EDGAR2Form 144 - Report of proposed sale of securities
11/7/202322:39EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 47,20

La tua Cronologia

NASDAQ
CRNX
Crinetics Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network